logo
  

ANI Pharmaceuticals Sees Annual Earnings Better Than Estimates - Update

(Adds Full-year Outlook)

Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):

Earnings: -$20.54 million in Q1 vs. $0.09 million in the same period last year.
EPS: -$1.27 in Q1 vs. $0.01 in the same period last year.
Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of -$1.98 million or -$0.12 per share for the period.

Analysts projected $0.09 per share
Revenue: $64.48 million in Q1 vs. $54.52 million in the same period last year.

For the full year, the company expects revenue between $295.0 million and $315.0 million, a growth of 36% to 46% from last year. On average, analysts polled by Thomson Reuters expect the company to report revenue of $292.77 million.

Adjusted EPS is expected in the range of $1.34-$1.62 for the year. The consensus estimate stands at $1.15 per share.


-Guidance:
Full year EPS guidance: $1.34 - $1.62
Full year revenue guidance: $295 - $315 Mln

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT